A study by the National Oncologic PET Registry shows that PET results influenced treatment decisions in more than a third of patients with ovarian, kidney, prostate and several other cancer types currently not covered by Medicare services. "The bottom line was that there was no cancer, that when carefully selected, that PET was not reasonable for," an NOPR investigator said. The researchers are hoping that the results of the study will urge the CMS to expand Medicare coverage of PET imaging.

Related Summaries